Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Multiple Center, Cross-sectional Study.

NCT03976739 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT03976739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03976739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Multiple Center, Cross-sectional Study.
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Observational
Overall status
Completed
Start date
June 17, 2019
Completion date
December 31, 2019
Enrollment
1,162 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile reflux gastritis, gastric cancer, helicobacter pylori infection, intestinal metaplasia, precancerous lesions